“Golden” standard in the treatment of nephrolithiasis of both kidneys in combination with severe concomitant pathology (case report)


  • V.A. Slobodyanyuk
Keywords: urolithiasis, nephrolithiasis, concomitant pathology, percutaneous nephrolithotripsy, clinical case

Abstract

The problem of urolithiasis remains one of the key in modern urology today. Urolithiasis, its recurrent nature, often-severe complications and invalidation of patients has a high medical and social significance. Recently, more and more urolithiasis occurs in oblique and aging years and is usually accompanied by a serious accompanying somatic pathology, which is characterized by significant violations. The latter, on the one hand, may be a risk factor for the development of urolithiasis, but on the other requires a careful approach to the choice of therapeutic tactics. Improvement of endoscopic equipment contributed to the active introduction of noninvasive methods of surgical treatment of nephrolithiasis in the clinical practice. The “golden” standard for the removal of large and cortical stones is, today, a transdermal nephrolithotripsy. The staff of the clinic of the Institute of Urology of the National Academy of Medical Sciences of Ukraine has a wealth of experience in the use of this method in the treatment of urolithiasis. The purpose of the work is to determine the effectiveness of percutaneous nephrolithotripsy in the treatment of nephrolithiasis in both kidneys, accompanied by severe comorbidity. The patient conducted general-clinical and biochemical tests of blood and urine, X-ray methods of examination, ultrasound examination of the abdominal cavity, MSCT. In the presented clinical observation in the patient, nephrolithiasis of both kidneys was diagnosed, accompanied by severe concomitant somatic pathology. Percutaneous nephrolithotripsy allowed two steps to remove all concrements, which once again proved the success of this method in the treatment of urolithiasis.

References

1. Alyaev, Yu. G. & Glybochko, P. V. (Red.). (2016). Mochekamennaya bolezn. Sovremennyj vzglyad na problemu. Rukovodstvo dlya vrachej [Urolithiasis disease. Modern view on the problem. A guide for doctors]. Moskva. ISBN978-5-9906972-5-6.

2. Vozianov, A. F. & Lyulko, A. V. (2001). Atlas: rukovodstvo po urologii (v 3 t.). [Atlas: a guide to urology (in 3 vol.)]. Dnepropetrovsk : RIA “Dnepr-VAL”. ISBN: 978-966-7616-21-2, 978-966-7616-20-5.

3. Voshula, V. I. (2015). Metafilaktika mochekamennoj bolezni [Metaprophylaxis of urolithiasis]. Zdorove muzhchiny – Male health, 1 (52), 4–8. ISSN 2307-5090.

4. Golovanov, S. A., Sivkov, A. V. & Anohin, N. V. (2015). Giperkalciuriya: principy differencialnoj diagnostiki [Hypercalciuria: principles of differential diagnosis]. Eksperimentalnaya i klinicheskaya urologiya – Experimental and Clinical Urology, 4, 86–93. Vzyato s https://ecuro.ru/sites/default/files/GOLOVANOV_0.pdf.

5. Dutov, V. V., Galko, A. A. & Rumyancev, A. A. (2015). Osobennosti diagnostiki i lecheniya mochekamennoj bolezni v sochetanii s infravezikalnoj obstrukciej u pacientov pozhilogo i starcheskogo vozrasta [Features of diagnosis and treatment of urolithiasis in combination with infravesical obstruction in patients of elderly and old age]. Medicinskie aspekty zdorovya muzhchiny – Medical aspects of male health, 3, 25–29.

6. Kustov, A. V., Strelnikov, A. I., Ajrapetyan, A. O., Moryganov, M. A. & Zhuravlyova, N. I. (2015). Diagnostika metabolicheskih narushenij i metafilaktika recidivnogo kalcij-oksalatnogo urolitiaza [Diagnosis of metabolic disorders and metaphylactics of recurrent calcium-oxalic urolithiasis]. Urologiya – Urology, 5, 86–88.

7. Merinov, D. S., Artemov, A. V., Epishov, V. A., Arustamov, L. D., Gurbanov, Sh. Sh. & Fatihov, R. R. (2016). Purkutannaya nefrolitotomiya v lechenii korallovidnyh kamnej pochek K3–K4 [Purcutaneous nephrolithotomy in the treatment of coral kidney stones K3 – K4]. Eksperimentalnaya i klinicheskaya urologiya – Experimental and clinical urology, 3, 21–33.

8. Rossikhin, V. V., Khoshchenko, Yu. A. & Osipov, P. H. (2000). Efektyvnist fitopreparatu Flavia u pisliaoperatsiinomu likuvanni khvorykh nefrolitiazom, yaki perenesly dystantsiinu udarno-khvylovu litotrypsiiu [Effective phytopreparatum Flavia u pisliaoperacinoma likuvanni khvorykh nefrolitiazom, yaki perenesly dystantsiinu udarno-khvylovu lithotripsy]. Zdorove muzhchiny – Male health, 4, 44–46.

9. Trapeznikova, M. F. & Dutov, V. V. (2000). Mochekamennaya bolezn u pozhilyh lyudej. V. Gorilovskij L. M. (Red.), Izbrannye glavy geriatricheskoj urologii [Urolithiasis in the elderly. In Gorilovsky L. M. (Ed.), Selected Chapters of Geriatric Urology] (p. 119–137). Moskva.

10. Filippova, T. V., Alyaev, Yu. G., Rudenko, V. I., Asanov, A. Yu., Gadzhieva, Z.K., Subbotina, T. I. & Perekalina, A. N. (2016). Geneticheskie aspekty mochekamennoj bolezni [Genetic aspects of urolithiasis]. Urologiya – Urology, 2, 95–102. Vzyato s https://urologyjournal.ru/ru/archive/article/33053.

11. Yanenko, E. K., Merinov, D. S., Konstantinova, O. V. & Epishov, V. A., Kalinichenko, D. N. (2012). Sovremennye tendencii v epidemiologii, diagnostike i lechenii mochekamennoj bolezni [Current trends in the epidemiology, diagnosis and treatment of urolithiasis]. Eksperimentalnaya i klinicheskaya urologiya – Experimental and clinical urology, 3, 19–24.

12. Hartman, C., Friedlander, J. I., Moreira, D. M., Elsamra, S. E., Smith, A. D. & Okeke, Z. (2015). Differences in 24–h urine composition between nephrolithiasis patients with and without diabetes mellitus. BJU Int., 115 (4), 619–24. Doi: 10.1111 (bju. 12807. Epub. 2014, Aug 13).

13. Nerli, R., Jali, M., Guntaka, A. K., Patne, P., Patil, S. & Hiremath, M. B. (2015). Type 2 diabetes mellitus and renal stones. Adv. Biomed. Res., 4, 180. Doi: 10.4103/2277–9175.164012.

14. Roudakova, K. & Monga, M. (2014). The evolving epidemiology of stone disease. Indian J. Urol., 30, 44–48. doi: 10.4103/0970-1591.124206.

15. Sansak, E. B., Resorlu, M., Akbas, A., Gulpinar, M. T., Arslan, M. & Resorlu, B. (2015). Do Hypertension, diabetes mellitus and obesity increase the risk of severity of nephrolithiasis? Pak. J. Med. Sci., 31 (3), 566–71. Doi:10.12669/pjms. 313.7086.

16. Semins, M. C., Shore, A. D., Makary, M. A., Magnuson, T., Cohns, R. & Matlaga, B. R. (2010). The association of increasing body mass indeks and kidney stone disease. C. Urol., 183, 571–75. doi: 10.1016/j.juro.2009.09.085.

17. Turk, C., Petrik, K., Sarica, K., Seitz, C., Skolarikos, A., Straub, M. & Knoll, T. (2016). EAU Guidelines of Interventional Treatment for Urolithiasis. Eur. Urol. 69, 475–482. Retrieved from https://uroweb.org/wp-content/uploads/EAU-Guidelines-Urolithiasis-2016-1.pdf.
Published
2018-09-28
How to Cite
Slobodyanyuk, V. (2018). “Golden” standard in the treatment of nephrolithiasis of both kidneys in combination with severe concomitant pathology (case report). Reports of Vinnytsia National Medical University, 22(3), 513-517. https://doi.org/https://doi.org/10.31393/reports-vnmedical-2018-22(3)-24